Abstracts tagged "discontinuation"

Abstract Number: 1428 • ACR/ARP Annual Meeting 2019
Time to Discontinuation of Tofacitinib in Rheumatoid Arthritis Patients with and Without Methotrexate: Results from a Rheumatoid Arthritis Cohort
Mohammad Movahedi¹, Angela Cesta ², Xiuying Li ², Edward Keystone ¹, Claire Bombardier ² and And Other OBRI Investigators ², ¹Division of Rheumatology, Mount Sinai Hospital, Toronto, ON, Canada, ²Toronto General Hospital Research Institute, University Health Network, Toronto, ON, Canada
Background/Purpose: Tofacitinib (TOFA) is an oral, small molecule drug which can be used as an alternative to biologic disease modifying antirheumatic drugs (bDMARDs) for rheumatoid…